Screener
BOUT vs BMAR
Innovator IBD Breakout Opportunities ETF vs Innovator U.S. Equity Buffer ETF - March
Key differences
- BMAR is significantly larger than BOUT — larger funds tend to be more liquid and less likely to close.
Side-by-side comparison
| BOUT | BMAR | |
|---|---|---|
| Annual cost (TER) | 0.80% | 0.79% |
| Fund size (AUM) | $16M | $227M |
| Since | 2018 | 2020 |
| Dividend yield | 0.28% | 0.00% |
| Asset class | alternative | alternative |
| Region | north america | north america |
| Strategy | structured outcome | structured outcome |
| CAGR 1Y | +36.1% | +23.1% |
| CAGR 3Y | +17.0% | +17.5% |
| CAGR 5Y | +8.8% | +12.6% |
| Sharpe 3Y | 0.74 | 1.29 |
| Volatility 1Y | 20.75% | 7.52% |
| Max drawdown | -36.75% | -21.43% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BOUT and BMAR
Explore further